COLL vs EIX
Collegium Pharmaceutical Inc (COLL) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the COLL and EIX stock pages for the full models.
Not investment advice.